Mount Sinai Launches Center for Psychedelic Research

Psilocybin Alpha:

The Icahn School of Medicine at Mount Sinai has launched a new center for psychedelics research. The Center for Psychedelic Psychotherapy and Trauma Research pursues a multipronged clinical and research approach to discovering novel and more efficacious therapies for post-traumatic stress disorder (PTSD), depression, anxiety, and other stress-related conditions in the veteran and civilian population. The Center will focus on studying MDMA, psilocybin, and other psychedelic compounds.

This is exciting news. The more psychedelic research centers the better, as far as I’m concerned.


A Former Mormon Politician Started A Psilocybin Church

Erin Hiatt, writing for DoubleBlind:

The Church of Jesus Christ of Latter-day Saints, formerly known as the LDS or Mormon Church, makes its home and headquarters in Salt Lake City, Utah, at the heart of the Wasatch Mountains. With its complex of Church headquarters, conference centers, and flagship Salt Lake Temple and surrounding Temple Square, the Church literally and figuratively imposes over the topography of downtown Salt Lake City. However, many would argue that the Church dominates more than just the downtown area—exerting an oversized pull over politics at the state capitol, a mere fifteen minute walk from church headquarters.

Steve Urquhart is deeply familiar with both the state capitol and the internal life of a faithful member of the Church. As a Republican, he formerly served as a Utah State Representative in the deeply conservative southwest corner of the state. Today, he is neither a lawmaker nor Latter-day Saint. Instead, he is the founder and “protector” of The Divine Assembly, a Salt Lake City-based psilocybin church.

A practicing lawyer, Urquhart is a straight-and-narrow-path kind of guy: He served a mission for the Church to Brazil, married his wife Sara in a Church, and raised his four children in the faith. He never wandered far from that path until he and his wife had a life-altering experience with ayahuasca in Amsterdam.

What a ballsy move. Psilocybin mushrooms are not legal in Utah and although there is some legal precedent for the religious use of psychedelics for some groups, The Divine Assembly is a brand-new religion and there’s no guarantee the U.S. government will deem either it or its practices to be legitimate.

If Urquhart’s church is allowed to continue using psilocybin mushrooms as a sacrament, other religious and spiritual groups may follow suit. However, there is a real possibility that they may soon find themselves arguing their case in court.

Personally, I find the idea of communing with the divine via entheogens to be completely reasonable and wish Urquhart luck in his quest to further establish a religious right to use psychedelics.


The Third (and Likely Final) Season of Hamilton's Pharmacopeia Is Out

In case you weren’t already aware, the third (and likely final) season of Hamilton’s Pharmacopeia started airing on VICE TV this week. I haven’t had a chance to watch any of it yet myself but I figured the Think Wilder audience would like to know that it’s out there. Apparently the first episode focuses on 5-MeO-DMT, and judging from the write-up on Psychedelic Science Review it sounds mighty interesting if you ask me.


The New Democratic Congress Is Expected to Approve Cannabis Legalization By 2022

Kyle Jaeger, writing for Marijuana Moment:

The Senate will vote to pass a bill to federally legalize marijuana within the next two years.

That’s according to the top Democratic lawmaker who is expected to be installed as majority leader following his party’s projected clean sweep in this week’s two Georgia runoff elections that will give them control of the chamber.

Coupled with Joe Biden’s presidential win, the new situation on Capitol Hill means that federal cannabis policy change is in the cards for the 117th Congress. While the former vice president has declined to embrace adult-use legalization, he’s pledged to adopt modest reforms such as marijuana decriminalization and expunging past records.

And a push from House and Senate Democratic leadership—who are already on record with pledges to advance far-reaching marijuana reforms—could lead to the comprehensive changes that advocates have been fighting for, including the advancement of a federal cannabis descheduling bill that cleared the House last month.

Although there’s been a lot of insanity happening on Capitol Hill this week, federally-legal cannabis might actually become a reality within the next two years. And even if Congress doesn’t approve legislation that would legalize marijuana nationwide (or at least deschedule it), several states are already working on state-level reforms that could take place later this year.

Of course all this is assuming that the United States still has a functioning democracy in the future. I’m not much of a betting man, but if I was then I’d wager that our country will recover from this week’s craziness and that weed will be legal by 2022—maybe even this year. Here’s hoping.


This Week in Psychedelics - 1.1.21

ThisWeekinPsychedelics.png

Cannabis

  • New York Lawmakers Prefile Eight Marijuana Bills For 2021 As State Pursues Legalization (Marijuana Moment)

  • New Jersey: Governor Delays Signing Adult-Use Legalization Legislation (NORML)

  • Mississippi And South Dakota Officials Defend Marijuana Ballot Measures Against Legal Challenges (Marijuana Moment)

  • Illinois Expunges Nearly Half a Million Cannabis Arrest Records 4 Years Ahead of Schedule (NBC Chicago)

  • Montana: Adult-Use Legalization Law Takes Effect (NORML)

  • Young Adults Who Vape Cannabis Are More Likely To Experience Cough, Bronchitis And Wheezing, Study Finds (CBS Baltimore)

  • Missouri Lawmaker’s New Bill Would Put Marijuana Legalization On 2022 Ballot (Marijuana Moment)

  • Study shows long-term cannabis use does not increase sensitivity to pain (The Spokesman-Review)

Magic Mushrooms

  • 2020 Was the Year of the Magic Mushroom (VICE)

MDMA

  • A Brief History of the Netherlands' Love Affair With Ecstasy (VICE)

Ketamine

  • Ketamine may ease depression by restoring the brain’s sensitivity to prediction error, study suggests (PsyPost)

  • Is Ketamine Effective for Typical and Atypical Depression? (Psychology Today)

Datura

Miscellaneous

  • D.C. Decriminalizes Possession Of Drug Paraphernalia And Promotes Harm Reduction (Marijuana Moment)

  • One psychedelic experience may lessen trauma of racial injustice (Ohio State News)

  • Why Canada Could Be Next To Allow Psychedelic Therapy (And How It’s Already Changing Lives) (Forbes)

  • The Psychedelic Renaissance in 2020 (Psilocybin Alpha)

  • The Crisis of “Soft” Drug Criminalization in Italy (Filter)

  • Remembering the Late Michael Alig, King of the Club Kids, Ex-Con Killer… And Unconventional Psychedelic Pioneer (DoubleBlind)

  • Psychedelics and Judaism (Reality Sandwich)

  • Legal Psychedelic Therapy Comes to Alberta With Ground-Breaking Health Canada Decision (Psilocybin Alpha)

  • Compassionate Use – Psychedelic Therapy for Those Who Can’t Wait (Psychedelic Science Review)

  • How UK Club Bouncers Prey On People Who Use Drugs (Filter)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.